Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Exact Sciences Celebrates 2 Years since Cologuard®’s FDA Approval

Two years ago this month, the Food and Drug Administration approved Exact Sciences’ Cologuard. The news on August 11, 2014 made Cologuard the first and only FDA-approved stool DNA screening test for colorectal cancer. It was also the first time in history that the FDA approved a technology and the Centers for Medicare & Medicaid Services (CMS) proposed a national coverage determination...Read more

CMS Affirms Cologuard® Covered Every Three Years for Medicare Advantage Beneficiaries Without Cost Sharing

 MADISON, Wis., Aug. 15, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced that the Centers for Medicare and Medicaid Services (CMS) issued an updated Evidence of Coverage notice for Medicare Advantage plans that affirms such plans must include coverage of Cologuard every three years without patient coinsurance, copayments or deductibles. "The CMS update assures...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com


View updates on upcoming conference appearances, company news, financial reports and more.

Learn More